G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,047,000 | -63.0% | 47,708 | -59.5% | 1.05% | -54.2% |
| Q1 2021 | $2,832,000 | +33.7% | 117,708 | 0.0% | 2.30% | +42.2% |
| Q4 2020 | $2,118,000 | -19.8% | 117,708 | -48.5% | 1.61% | -22.6% |
| Q3 2020 | $2,640,000 | -70.9% | 228,597 | -38.9% | 2.08% | -67.2% |
| Q2 2020 | $9,070,000 | +132.9% | 373,876 | -1.1% | 6.35% | +65.6% |
| Q1 2020 | $3,895,000 | -64.4% | 378,145 | -8.8% | 3.83% | -47.8% |
| Q4 2019 | $10,953,000 | – | 414,408 | – | 7.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |